Inogen (INGN) PT Raised to $55 at Leerink Partners
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Inogen (INGN) Reports Q2 EPS of $0.17; Raises Outlook
August 11, 2015 4:15 PM EDTInogen (NASDAQ: INGN) reported Q2 EPS of $0.17, versus $0.11 reported last year. Revenue for the quarter came in at $44 million, versus $30.4 thousand reported last year.
Inogen raised FY2015 revenue guidance to $145-149 million, versus prior guidance of $133-137 million.
"Our record revenues in the second quarter reflect exceptionally strong performance across all of our sales channels, as well as the benefit of seasonality. Net income and Adjusted EBITDA also reached record levels, demonstrating our substantial... More
